Last update :
20/02/2026
References   References 5123  
Type : Poster
Icone.pdf
792Ko

Research teams : Toronto - Sunnybrook Health Sciences Center
Authors : Charbonneau L, Tyono I, Shloush J, Law S, Ma N.
Title : Stability and compatibility of oxaliplatin and generic medical partners Inc.'s leucovorin formulation.
Reference : Sunnybrook Health care Ce 2025

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionFolinate calcium Cytoprotective
Compatible 0,35 >>1,54 mg/ml + injectionOxaliplatin 0,2 mg/ml + Glucose 5%
Compatible 0,35 >>1,54 mg/ml + injectionOxaliplatin 0,7 mg/ml + Glucose 5%
injectionOxaliplatin Anticancer drug
Compatible 0,2 mg/ml + injectionFolinate calcium 0,35 >>1,54 mg/ml + Glucose 5%
Compatible 0,7 mg/ml + injectionFolinate calcium 0,35 >>1,54 mg/ml + Glucose 5%

  Mentions Légales